The emerging role of ACOD1/itaconate pathway in atherosclerosis.

Trends Mol Med

Department of Endocrinology, Institute of Endocrine and Metabolic Disease, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230022, China. Electronic address:

Published: September 2024

As an endogenous immunometabolite, itaconate has excellent anti-inflammatory effects. However, it remains unknown whether itaconate protects against atherosclerosis. Two recent studies, by Song et al. and Cyr et al., revealed the emerging role of the aconitate decarboxylase 1/itaconate pathway in atherosclerosis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molmed.2024.05.015DOI Listing

Publication Analysis

Top Keywords

emerging role
8
pathway atherosclerosis
8
role acod1/itaconate
4
acod1/itaconate pathway
4
atherosclerosis endogenous
4
endogenous immunometabolite
4
immunometabolite itaconate
4
itaconate excellent
4
excellent anti-inflammatory
4
anti-inflammatory effects
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!